Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.

Shrestha S, Wang C, Aissani B, Wilson CM, Tang J, Kaslow RA.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1626-32.

2.

Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.

Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H.

AIDS. 2007 Nov 12;21(17):2283-91.

PMID:
18090276
3.

Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women.

Koshiol J, Schroeder J, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, Celentano D, Smith JS.

Am J Epidemiol. 2006 Jul 15;164(2):176-83. Epub 2006 Jun 14.

PMID:
16775041
4.

The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.

Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, N'Doye I, Kiviat NB.

J Infect Dis. 2007 Sep 15;196(6):887-94. Epub 2007 Aug 7.

PMID:
17703420
5.

Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

Moscicki AB, Ellenberg JH, Farhat S, Xu J.

J Infect Dis. 2004 Jul 1;190(1):37-45. Epub 2004 Jun 8.

PMID:
15195241
7.

Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women.

Tornesello ML, Duraturo ML, Giorgi-Rossi P, Sansone M, Piccoli R, Buonaguro L, Buonaguro FM.

J Gen Virol. 2008 Jun;89(Pt 6):1380-9. doi: 10.1099/vir.0.83553-0.

PMID:
18474553
8.

Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV.

Fontaine J, Hankins C, Money D, Rachlis A, Pourreaux K, Ferenczy A; Canadian Women's HIV Study Group, Coutlée F.

J Clin Virol. 2008 Nov;43(3):307-12. doi: 10.1016/j.jcv.2008.07.013. Epub 2008 Sep 10.

PMID:
18786854
9.

Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.

Wieczorek S, Hellmich B, Arning L, Moosig F, Lamprecht P, Gross WL, Epplen JT.

Arthritis Rheum. 2008 Jun;58(6):1839-48. doi: 10.1002/art.23496.

10.

Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection.

Nicol AF, Fernandes AT, Grinsztejn B, Russomano F, E Silva JR, Tristão A, Pérez Mde A, Nuovo GJ, Martínez-Maza O, Bonecini-Almeida Mda G.

Diagn Mol Pathol. 2005 Mar;14(1):39-47.

PMID:
15714063
11.

Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection.

Behbahani H, Walther-Jallow L, Klareskog E, Baum L, French AL, Patterson BK, Garcia P, Spetz AL, Landay A, Andersson J.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):9-19.

PMID:
17356467
12.

Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women.

Grinsztejn B, Veloso VG, Levi JE, Velasque L, Luz PM, Friedman RK, Andrade AC, Moreira RI, Russomano F, Pilotto JH, Bastos FI, Palefsky J.

Int J Infect Dis. 2009 Jan;13(1):72-80. doi: 10.1016/j.ijid.2008.03.031. Epub 2008 Jul 15. Erratum in: Int J Infect Dis. 2009 Sep;13(5):655-6.

13.

Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance.

Oleksyk TK, Thio CL, Truelove AL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW.

Genes Immun. 2005 Jun;6(4):347-57.

PMID:
15815689
14.

Polymorphism of the L1 capsid gene and persistence of human papillomavirus type 52 infection in women at high risk or infected by HIV.

Gagnon S, Hankins C, Money D, Pourreaux K; Canadian Women's HIV Study Group, Franco E, Coutlée F.

J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):61-5.

PMID:
17075388
15.

Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection.

Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M, Nakitare GW, Ichimura H, Inoue M.

J Med Virol. 2008 May;80(5):847-55. doi: 10.1002/jmv.21170.

PMID:
18360898
16.

TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer.

Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM.

J Infect Dis. 2005 Mar 15;191(6):969-76. Epub 2005 Feb 8.

PMID:
15717274
17.

Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women.

Harris TG, Burk RD, Xue X, Anastos K, Minkoff H, Massad LS, Young MA, Levine AM, Gange SJ, Watts DH, Palefsky JM, Strickler HD.

AIDS. 2007 Sep 12;21(14):1933-41.

PMID:
17721101
18.

CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women.

Su TH, Chang TY, Lee YJ, Chen CK, Liu HF, Chu CC, Lin M, Wang PT, Huang WC, Chen TC, Yang YC.

Carcinogenesis. 2007 Jun;28(6):1237-40. Epub 2007 Mar 6.

PMID:
17341658
19.

Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.

Kaur G, Singh P, Rapthap CC, Kumar N, Vajpayee M, Sharma SK, Wanchu A, Mehra NK.

Hum Immunol. 2007 May;68(5):454-61. Epub 2007 Feb 20.

PMID:
17462514
20.

HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.

Mahmud SM, Robinson K, Richardson H, Tellier PP, Ferenczy AS, Roger M, Coutlee F, Franco EL.

J Infect Dis. 2007 Jul 1;196(1):82-90. Epub 2007 May 29.

PMID:
17538887

Supplemental Content

Support Center